glp-1 drugs and autoimmune disease Genetics: How Genes Affect Appetite, Semaglutide, Tirzepatide Response glp 1 drugs and autoimmune
Description
Secondary summaries, including this article, are no substitute for reading the actual trial data and understanding the methodology behind the headline numbers
The dual GIP/GLP-1 mechanism of tirzepatide creates a slightly different side effect pattern
The potential of the emerging Glucagon-like Peptide-1 (GLP-1) Agonists in changing the current clinical practice guidelines is crucial to analyze, especially when it comes to real-world scenarios
In the first half of 2025, Mounjaro sales alone approached several billion dollars, putting it on track to challenge Novos Wegovy/Ozempic for the highest sales in the weight loss/diabetes class
We need to be very mindful of any products that may not be proven and therefore may have no effect or unknown negative consequences
White adipose tissue dysfunction in obesity and aging
